当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 利润表

复星医药

(600196)

39.91

1.50  (3.91%)

今开:38.42最高:40.09成交:14.71万手 市盈:0.00 上证指数:3199.16   0.45%2018-02-14
昨收:38.41 最低:38.41 换手:0.00%振幅:0.00 深证指数:10431.91  0.67%15:31:00

集合

竞价

利润表

按照会计年度查询:
报告期2011-03-312010-12-312010-09-302010-06-30
一、营业总收入1,454,571,780.374,555,421,686.793,328,591,698.432,194,921,691.32
营业收入1,454,571,780.374,555,421,686.793,328,591,698.432,194,921,691.32
二、营业总成本1,457,421,938.384,642,209,601.573,290,869,254.852,170,012,235.22
营业成本950,805,903.192,984,560,514.042,189,289,682.641,458,121,946.18
营业税金及附加10,499,064.2826,648,602.9419,909,521.2612,230,065.92
销售费用249,840,035.93798,274,857.75560,507,163.33365,430,787.91
管理费用183,723,965.49569,618,902.66403,999,738.82255,395,091.71
财务费用61,342,433162,564,909.81110,104,779.0478,335,308.31
资产减值损失1,210,536.49100,541,814.377,058,369.76499,035.19
三、其他经营收益245,630,222.75551,264,511.25195,017,199.8170,336,754.49
允许价值变动净收益24,830,685.4545,449,849.47--0
投资净收益298,538,710.971,181,792,144.4951,310,555.11748,310,794.9
联营、合营企业投资收益163,790,711.27552,331,403.34404,199,820.75276,239,249.37
汇兑净收益--------
四、营业利润320,519,238.411,140,454,079.09989,032,998.69773,220,251
营业外收入8,079,701.3269,480,852.0441,513,304.6723,349,668.07
营业外支出508,495.097,983,617.873,085,528.481,437,875.91
非流动资产处置净损失58,060.84617,362.98116,870.21157,158.96
五、利润总额328,090,444.641,201,951,313.261,027,460,774.88795,132,043.16
所得税42,539,849.72201,607,494.24186,754,256.59163,666,141.42
未确认的投资损失--------
六、净利润(百万元)252.48863.65738.01551.44
少数股东损益33,072,903.45136,689,912.22102,694,873.3880,026,697.86
归属于母公司股东的净利润252,477,691.47863,653,906.8738,011,644.91551,439,203.88
七、每股收益--------
基本每股收益0.130.460.390.44
稀释每股收益0.130.460.39--
TOP↑